azasan

Generic: azathioprine

Labeler: salix pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name azasan
Generic Name azathioprine
Labeler salix pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

azathioprine 100 mg/1

Manufacturer
Salix Pharmaceuticals

Identifiers & Regulatory

Product NDC 65649-241
Product ID 65649-241_85aaaf8a-26bf-4878-9356-490f17fe65ef
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075252
Listing Expiration 2026-12-31
Marketing Start 2003-04-01

Pharmacologic Class

Established (EPC)
purine antimetabolite [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]
Chemical Structure
nucleosides [cs] purines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65649241
Hyphenated Format 65649-241

Supplemental Identifiers

RxCUI
359228 359229 404475 404476
UPC
0365649231414
UNII
MRK240IY2L
NUI
N0000000233 M0015066 N0000175712 M0018169

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name azasan (source: ndc)
Generic Name azathioprine (source: ndc)
Application Number ANDA075252 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (65649-241-41)
source: ndc

Packages (1)

65649-241-41 100 TABLET in 1 BOTTLE (65649-241-41)

Ingredients (1)

azathioprine (100 mg/1)

Linked Drug Pages (1)

Azasan ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "85aaaf8a-26bf-4878-9356-490f17fe65ef", "openfda": {"nui": ["N0000000233", "M0015066", "N0000175712", "M0018169"], "upc": ["0365649231414"], "unii": ["MRK240IY2L"], "rxcui": ["359228", "359229", "404475", "404476"], "spl_set_id": ["9050af7a-19c6-4670-937a-9445605de995"], "pharm_class_cs": ["Nucleosides [CS]", "Purines [CS]"], "pharm_class_epc": ["Purine Antimetabolite [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Salix Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (65649-241-41)", "package_ndc": "65649-241-41", "marketing_start_date": "20030401"}], "brand_name": "Azasan", "product_id": "65649-241_85aaaf8a-26bf-4878-9356-490f17fe65ef", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleosides [CS]", "Purine Antimetabolite [EPC]", "Purines [CS]"], "product_ndc": "65649-241", "generic_name": "Azathioprine", "labeler_name": "Salix Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azasan", "active_ingredients": [{"name": "AZATHIOPRINE", "strength": "100 mg/1"}], "application_number": "ANDA075252", "marketing_category": "ANDA", "marketing_start_date": "20030401", "listing_expiration_date": "20261231"}